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Abstract
Background A national surveillance program of colon cancer
treatment was introduced in 2007. We examined prognostic
factors for colon cancer operated in 2000 with an aim of
improving survival in the new program and a special focus on
the merit of lymph node yield.
Methods A cohort of 269 patients, 152 women (56.5%), with
a mean age of 71 years, was operated for colon cancer in 2000
at three teaching hospitals and followed up for 7 years.
Results Overall 5-year survival was 58.0%, and overall
hospital mortality was 5.2%, with 4.5% in elective cases
and 12.5% after urgent surgery. In only 41.1% of the
specimens were 12 or more lymph nodes retrieved, but this
did not affect survival in the combined cohort, although one
of the hospitals achieved a significantly better result with a
harvest of 12 or more lymph nodes. In a multivariate
analysis, old age, gender, a high lymph node ratio (LNR) at
stage III, and tumor–node–metastasis stage were adverse
factors for survival.
Conclusions The operative mortality was high and should
be reassessed. The lymph node count did not have a
significant impact on outcome overall, whereas the LNR
proved significant for stage III. A prospective protocol
using overall lymph node yield as a surrogate measure for
more radical surgery, nevertheless, seems warranted to
improve the lymph node harvest according to international
recommendations.
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Introduction
In recent years, the results after surgery for rectal cancer in
Norway, with a 5-year overall survival (OS) rate of 60.1%,
has surpassed that of colon cancer at 57.5% [1]. This has
been achieved because the surgical technique has been
standardized according to total mesorectal excision (TME)
with subsequent dramatic reductions of local recurrences.
Beginning in 2007, all colon cancers were to be reported
separately to the Norwegian National Cancer Registry in an
effort to systematically survey and hopefully improve
results. Nevertheless, a national strategy to standardize
surgical treatment along the lines of radical surgery has
neither been implemented in detail nor been generally
accepted [2, 3].
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In this respect, the number of lymph nodes retrieved
may act as a surrogate measure of radical surgery. The
survival benefit of a large lymph node harvest has been
shown in several reports [2–4]. It has been accepted
nationally to offer patients with tumor–node–metastasis
(TNM) stage III below a certain age, usually 75 years,
adjuvant chemotherapy. This depends on adequate staging
and lymph node sampling. It has been decided that a rather
arbitrary level of 12 retrieved nodes is enough to obtain
adequate surgery and staging. Pathologists may be a key
factor for optimal lymph node harvest, and a conjoined
effort between surgeon and pathologist would be ideal to
improve results [2–6].
The aim of the study was to examine, after modest
radical colon surgery removing mesocolic nodes and focus
on lymph node yield, what would influence survival and
where surgical improvement might be possible using data
from a cohort of patients from three large Norwegian
teaching hospitals.
Material and methods
Patients from a national cohort were operated in 2000, and
follow-up was until December 2007, a mean of 7.5 years
later. Three teaching community hospitals, Haraldsplass
Deaconal Hospital, Stavanger University Hospital, and
Akershus University Hospital contributed patients.
Surgery
All three hospitals are teaching community hospitals,
and the patients were operated with an open access by
a large number of surgeons. At that time, extra radical
surgery was unusual, and it is fair to assume that
radical surgery usually constituted a moderate meso-
colic resection. If metastases were diagnosed, patients
and tumor conditions were assessed regarding feasibility
for resection.
Follow-up
Patients usually went to the outpatient clinic every third
month for the first 2 years and then every sixth month
until 5 years had passed. Blood tests with carcino-
embryonic antigen measurement and ultrasonography of
the liver and chest X-ray were carried out. Elderly
patients are stead-bound and even if a few of them were
not followed up frequently, they could be tracked and
life status ascertained through their identity number in
the official National Population Registry. Death certifi-
cates for all deceased patients were available through
Statistics, Norway.
Pathology
The specimen was examined and rinsed by the surgeons
on the back table before being mounted on a board and
placed in a box filled with enough formaldehyde for
secure fixation. The specimen was examined by a junior
pathologist; after 48–72 h, assisted by the consultant.
Lymph nodes were harvested by sight and palpation. A
minimum sampling of 12 lymph nodes was aimed for.
Tissue was paraffin-embedded, and hematoxylin–eosin
staining was used routinely before sections were
examined microscopically. Metastatic deposits were
defined as lymph nodes if these structures resembled
nodes but without containing visible lymphatic tissue.
The large intestine was defined as ending 16 cm from
the anus. The TNM classification 5th edition was used
for staging.
Oncology
Patients younger than 75 years of age that were
classified as TNM stage III were offered 12 courses of
adjuvant treatment with 5-fluorouracil plus calsiumfolinate
(FLV).
Ethics
The Regional Committee for Medical and Health Research
Ethics of Western Norway and the Data Inspectorate for
National Registries approved the study. The study is part of
a prospective project registered with clinicaltrials.gov
(NCT00963352).
Statistical analysis
The chi-square test was used to compare groups with
respect to categorical variables and analysis of variance for
continuous variables. The following variables were ana-
lysed with respect to survival: hospital, age, gender,
location, no of lymph nodes and lymph node ratio (LNR),
T stage, and TNM stage. Survival curves were estimated by
the Kaplan–Meier method [7] and compared using the log-
rank test [8]. Multiple prognostic factors were analysed
with the Cox proportional hazards model [9] using the
SPSS 17 package.
Results
Two hundred sixty-nine patients, 152 (56.5%) women and
117 men, with a mean age of 71 years (range, 20–93 years)
were studied. One of the hospitals operated male patients
that were younger, with a mean of 67 years.
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Surgery
The different tumor locations are shown in Table 1. Tumor
locations were not different between the hospitals (p=0.059).
Right hemicolectomy and sigmoid resection were the most
common procedures (78.4%). Locoregional R0 resections for
a single tumor location were done in 264 patients, while
double resections (n=4) and a suspected locoregional R1
resection (n=1) were done in five patients.
Pathology
There were no significant differences between hospitals
relating to TNM stage distribution: 34 patients (12.6%)
were stage I, 116 patients (43.1%) were stage II, 93 patients
(34.6%) were stage III, and 26 patients (9.6%) were stage
IV. The number of lymph nodes harvested for various
stages were 8.7 (stage I), 10.3 (stage II), 10.9 (stage III),
and 10.3 (stage IV). In 11 patients, the pathologist had
classified the T category and TNM stage but omitted to
specify the number of lymph nodes present. The mean
number in 258 patients was 10.3 lymph nodes per
specimen. Twelve or more lymph nodes were examined in
41.1% (106/258) of the resected specimens. Significantly
fewer lymph nodes (p<0.001) were harvested at one of the
hospitals. Otherwise, the three patient populations had
similar characteristics.
Survival analysis
Overall in-hospital mortality was 5.2% (14/269; range, 4.3–
6.3%). Urgent surgery had a mortality of 12.5% (3/24),
whereas the elective group had a mortality of 4.5% (11/
245). The 5-year OS was 58.0% (Fig. 1) and did not differ
between the hospitals (log-rank p=0.372; Fig. 3).
Whether categorizing number of lymph nodes harvested
in three groups (<10, 10–19, 20 or more) or in two (<12, 12
or more), no differences was found in OS (log-rank p=0.423
and 0.270, respectively). This was still the case after
adjusting for hospital or TNM stage (log-rank p=0.449).
The uncategorized number of lymph nodes was not
significant in a simple Cox regression (likelihood ratio
p=0.129). However, in one hospital, better survival was
found when the lymph node harvest was ≥12 compared to
<12 (log-rank p=0.037) as shown in Fig. 2. Stage II patients
had OS of 72.7% with ≥12 nodes harvested and 58.3% with
<12 nodes (p=0.124), and stage III patients had a 5-year OS
of 61.5% and 55.6%, respectively (p=0.508).
In stage III patients, the lymph node ratio (LNR) was
highly significant for patient survival, and OS for LNR 1
(<0.25) was 83.3.5%, LNR 2 (0.25–0.50) 63.3%, LNR 3
(0.51–0.75) 18.8%, and LNR 4 (0.76–1) 18.2% (log-rank
test p<0.001). The total number of lymph nodes was not
significant for stage III patients.
Two of the hospitals did more resections of T4 tumors
(chi-square test p=0.021). Adjusted for hospital, T4 tumors
compared to T1–T3, was a significant adverse factor for
survival in the log-rank test (p=0.049).
Survival according to the different TNM stages is shown
in Table 2. The 5-year OS was 58.1% for stage III and
63.8% for stage II without differences between the hospitals
in uni- and multivariate analyses. OS for stage IV was
significantly worse (p<0.001).
The results of univariate and multivariate Cox-regression
analyses are shown in Table 3. In the univariate Cox
regression old age, T category, high LNR, and TNM stage
Variables All patients Chi-square test
n=269 p value
Location 0.059
Right hemicolon 115 (42.8)
Transverse colon including flexures 44 (16.4)
Descending colon 9 (3.3)
Sigmoid colon and rectosigmoid 96 (35.7)
Multiplea or R1–2b 5 (1.9)
T category 0.021
T1 11 (4.1)
T2 30 (11.2)
T3 180 (66.9)
T4 48 (17.8)
TNM stage 0.098
I 34 (12.6)
II 116 (43.1)
III 93 (34.6)
IV 26 (9.7)
Table 1 Tumor locations and
pathology variables of patients
resected for colon cancer at
three teaching community
hospitals in 2000
a Resection of two tumors in
separate locations
b No radical loco-regional tumor
resection
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were adverse factors for survival. Age as a variable was
highly significant both as a continuous variable and with
a cutoff value of 69 years. Locations of the tumors with
regard to the various resected segments were not
significant (Table 3).
In the multivariate model age, male gender, high LNR,
and TNM stage were adverse factors (Figs. 4, 5, and 6). In
the fully adjusted multivariate analysis, T category was not
significant, but when removing TNM stage from the
multivariate model, the T category again became significant
(p=0.047). These variables were not significant: hospital,
tumor location, or number of harvested lymph nodes in
these categories (<10, 10–19, ≥20). LNR was also highly
significant for stage III patients (n=93) when adjusted for
all the variables in Table 3 in a multivariate Cox regression
with HRs (95% CIs) of 1.72 (0.80, 3.67), 5.16 (2.48,
10.74), and 4.80 (1.92, 11.99) for LNR 2–4 vs. LNR 1,
respectively (p<0.001).
Statistical analysis
The study may have been underpowered for detection of an
assumed difference between patients with a lymph node
harvest of <12 lymph nodes and those with >12. With the
number of patients included in our study, a power of at least
0.84 would be necessary to detect a difference in 5-year
survival of 50% vs. 68%. An increase in sample size to
detect a difference of 50% vs. 60% with a power of 0.80 in
a one-tailed chi-square test would require 305 patients in
each group.
Discussion
Even though several groups have pioneered radical surgery
for colon cancer (complete mesocolic excision and a central
tie) with its potential benefits similar to (TME) of rectal
cancer surgery, such an approach has not been widely
adopted in our country. Therefore, we wanted to examine
our background results based on a less standardized
approach and potential areas for improvement before
embarking on more radical procedures as championed by
others [2].
The 5-year overall survival (OS) for all three hospitals
was 58.0%. Advanced TNM stage had an adverse influence
on outcome, as the results for stage IV versus I–III and
Fig. 2 Kaplan–Meier survival curve for 103 patients resected for
colon cancer in one of three Norwegian hospitals in 2000. Patients
with a lymph node harvest of 12 or more showed significantly better
overall survival (log-rank test p=0.037)
Fig. 1 Kaplan–Meier survival curve for 269 patients resected for
colon cancer in three Norwegian hospitals in 2000
Table 2 Five-year overall survival (OS) according to the different
TNM stages for 269 patients treated with resection for colon cancer in
three Norwegian teaching community hospitals in 2000
TNM stage n (%) % OS
I 34 (12.6) 76.5
II 116 (43.1) 63.8
III 93 (34.6) 58.1
IV 26 (9.7) 7.7
All stages 269 (100) 58.0
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stage III versus I–II were significant in themultivariate analysis.
For stage III patients, the 5-year OSwas 58.1%. In one hospital,
the 5-year OS for stage III was worse with 47.8%. In the
multivariate analysis, however, when adjusted for hospital,
there was no significant survival difference. A recently
published international multicenter study of a colorectal
population [10] reported an identical OS of 58.8% for patients
treated in 2000–2002. Others have found a 5-year OS of
90.7–96.3% for stage II and 64.6–71.7% for stage III using
radical surgical procedures [2]. Thus, we consider our figures
to show room for improvement, although where improvement
may be best realised is debatable.
An advanced stage may theoretically be better treated
with more radical surgery even though the presence of skip
lesions in rare instances may hardly explain this [11].
Radical or complete mesocolic excision has been shown to
increase both the absolute lymph node harvest and
prognosis for the patients [2, 3]. However, it has been
contested that patients will benefit from more radical
surgery in advanced cases [12]. In a Swedish population-
based retrospective study [13], a median number of six
lymph nodes were detected in the specimens from 1,856
patients operated between 1996 and 2000. The patients in
that study had a high local recurrence rate of 11.5%.
Locations in the right flexure or left colon were independent
risk factors for outcome. There were a very low number of
nodes in the specimens from the left colon, whereas in the
right flexure tumors, the lymph node count was not inferior. In
both instances, the feeding vessel areas were not divided
completely, i.e., the inferior mesenteric artery proximally and
the root of the medial colic artery. In a population-based study
from The Netherlands by Kelder and co-workers, the median
lymph node harvest was six and in only 21% of the specimens
were 12 or more nodes examined [14]. Thus, we consider that
the principle of radical colon surgery may have been violated
in these studies when tumors were in those locations. More
Table 3 Univariate (n=269 patients) and multivariate (n=258) Cox regression models for analysis of overall survival for patients resected for
colon cancer in three Norwegian teaching community hospitals in 2000
Univariate Multivariatea LR test
HR 95% CI p value HR 95% CI p value
No. of sampled lymph nodes per increments of 10a 0.79 (0.58, 1.08) 0.129 0.82 (0.57, 1.17) 0.266
T category <0.001 0.129
T1–T2 1 (reference) 1 (reference)
T3 1.69 (0.94, 3.03) 1.84 (0.55, 6.15)
T4 3.38 (1.79, 6.40) 2.64 (0.78, 8.99)
Tumor location 0.568 0.716
Right colon 1 (reference) 1 (reference)
Transverse colon 0.89 (0.55, 1.46) 0.79 (0.47, 1.32)
Descending colon 0.97 (0.39, 2.42) 1.44 (0.57, 3.66)
Sigmoid colon 0.70 (0.45, 1.10) 0.81 (0.50, 1.31)
Rectosigmoid 0.82 (0.44, 1.53) 0.62 (0.31, 1.26)
Other/double 0.96 (0.23, 3.93) 0.67 (0.15, 2.91)
R2 5.83 (0.79, 42.81) 0.61 (0.08, 4.94)
Age per 10 years 1.46 (1.23, 1.74) 0.001 1.68 (1.38, 2.03) <0.001
Gender 0.192 0.031
Females 1 (reference) 1 (reference)
Males 1.26 (0.89, 1.77) 1.52 (1.04, 2.23)
TNM stage <0.001 <0.001
I 1 (reference) 1 (reference)
II 1.61 (0.82, 3.18) 0.91 (0.23, 3.69)
III 2.07 (1.05, 4.12) 1.49 (0.39, 5.66)
IV 10.50 (4.94, 22.32) 9.26 (2.15, 39.85)
Hospital 0.390 0.169
AHUS 1 (reference) 1 (reference)
SUS 1.06 (0.71, 1.60) 0.72 (0.46, 1.14)
HDS 1.34 (0.87, 2.07) 0.62 (0.37, 1.03)
HR hazard ratio; CI confidence interval; LR likelihood ratio; SUS Stavanger University Hospital; HDS Haraldsplass Deaconal Hospital; AHUS
Akershus University Hospital
a Analyses based on 258 patients because of lack of specified number of lymph nodes
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radical surgery for colon cancer has been recommended
in reports from the USA, Europe, and Japan [2, 15, 16].
A retrospective national report based on a small number
with supposedly radical colon surgery found that this
approach significantly increased survival compared with
a much larger and older group subject to a “standard”
procedure [17].
The number of lymph nodes may be seen only as a
surrogate marker for the extent of surgery without a proper
Fig. 6 Kaplan–Meier survival curves for 269 patients resected for
colon cancer in three Norwegian hospitals in 2000 according to TNM
stage (log-rank test p<0.001)
Fig. 5 Kaplan–Meier survival curves for 93 patients resected for
colon cancer in three Norwegian hospitals in 2000 according to lymph
node ratio groups: <0.25 (group 1), 0.25–0.5 (group 2), 0.51–0.75
(group 3), and >0.75 (group 4) (log-rank test p<0.001)
Fig. 4 Kaplan–Meier survival curves for 269 patients resected for
colon cancer in three Norwegian hospitals in 2000 according to age
(log-rank test p<0.001)
Fig. 3 Kaplan–Meier survival curves for 269 patients resected for
colon cancer in three Norwegian hospitals in 2000 according to
hospital (log-rank test p=0.372)
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oncologic explanation for the importance of a large harvest
[2, 3]. The node count has been correlated to survival both
for stage II and III disease [2, 18]. The oncologic
explanation is particularly lacking for stage II tumors [12].
The Ontario Cancer Registry study [19] showed better
survival with a lymph node harvest of more than ten lymph
nodes. Increasing the number even more did not improve
survival. In contrast, there is good evidence reported by
others that increasing the total number of lymph nodes
increases survival significantly [2, 4]. In one study, a mean
harvest of more than 28 lymph nodes was reported [2].
Data from the SEER database demonstrated that a cutoff
value of 15 was useful, and perhaps, there is an inherent
limit to the number of nodes necessary to achieve this effect
on survival [20]. Nevertheless, the hypothesis that a larger
(negative) lymph node yield is beneficial is contradicted
even from highly rated institutions [21]. Only 41% of our
patients had more than 12 nodes detected in the specimen.
In the univariate analysis, one of the hospitals achieved a
significantly better survival with a harvest of more than 12
lymph nodes. However, no significant survival benefit was
found with harvest of more than 12 lymph nodes in the
multivariate analysis. Several confounding factors may
have been present [21, 22]. Many pathologists were
involved in this trial even though the specimen handling
was supposed to be equal. In a recent study, the pathologist
was found to be the dependent factor in lymph node harvest
in multivariate analysis, not the operating surgeon [6]. The
overall poor lymph node harvest may also indicate that
more extensive surgery is one way to improve outcome as
found in one of the hospitals. It may be speculated that the
poorer outcome in the other two hospitals may have
levelled out any benefit by an improved lymph node
harvest, i.e., more radical surgery. The power of the study
may have concealed such a result [21].
Patients below 75 years were given FLV chemotherapy,
and staging was considered important for that reason. For
proper staging of colon cancer, the minimum number of
lymph nodes needed has been somewhat arbitrarily sug-
gested as 12 by a National Cancer Institute expert panel
[15]. Although some authors [14, 18] have concluded with
stage migration as an explanation for an increased survival
benefit, other studies have shown that detection of positive
nodes beyond six or seven lymph nodes examined had no
effect on staging [19, 23]. Thus, stage migration is
debatable and should not be taken for granted [24]. Patient
and tumor factors may also contribute to a variable lymph
node presence [18]. Doubtless, a standardized surgical
approach in cooperation with a dedicated pathology service
is necessary if a minimum number of nodes shall be found
and consequently help in outcome assessment. The mean
number of lymph nodes in our series was 10.3. Therefore,
under-staging was not considered important in our study
[24]. The share of stage III tumors equalled that reported by
others from large cohorts [12].
Studies have shown that the LNR is an independent and
better marker than pN+ for survival [25]. In our study, LNR
was highly significant for OS when adjusted for hospitals in
the multivariate analysis. Five-year OS varied from 83.5%
in LNR group 1, 63.3% in LNR 2, to 18.8% in LNR group
3. According to Wang et al. [26, 27], the prognostic effect
of LNR did not depend on the total number of lymph nodes
nor on the number of positive nodes. In contrast, Berger et
al. [25] found that LNR was not a significant prognostic
indicator with less than ten examined nodes but became
highly significant for OS and disease-free survival with
more than ten lymph nodes harvested. A Mayo Clinic study
[21] found a positive correlation between the number of
positive lymph nodes and survival but did not analyze the
effect of LNR. Fifty-eight percent of our stage III patients
had less than 12 lymph nodes examined. Still, we found a
significant survival difference of 44.5% between LNR
group 2 and 3 and 65.3% between group 1 and 4. A study
from New Zealand [22] found that both the absolute
number of lymph nodes retrieved up to 16, as well as the
LNR, were important for prognosis. The share of stage III
compared to stage II cancers in their patients amounted to
54.9%, higher than in most other reports. It seems obvious
that a large negative lymph node yield will down-regulate
LNR, but the importance of this with regard to outcome
may need to be examined in more detail.
Another national report of colon cancer from a single
institution found that an emergency operation, some colon
locations, blood transfusion of more than two units, old
age, and TNM stage were negative predictive factors [28].
No information about lymph node harvest was given. We
did not study the effect of blood transfusion, and
emergency operations were not separated from the rest
partly because they were few, i.e., 15% reported by Sjo et
al. [28], and the definition may be debatable. Information
about tumor obstruction or perforation would be more
appropriate in our opinion. The different colon locations
found to be statistically significant (transverse, left flexure,
and descending colon) were not so in our multivariate
analysis. We suspect that this is partly because they were
too few, 20%, to make an impact [28].
Old age was another adverse factor in our study. The
overall in-hospital mortality in our series was 5%. Even
though the number of urgently operated patients was small
in this series, as expected, this small group had a higher
mortality of 12.5% compared to 4.5% in the elective
patients. Severe co-morbidities in old age may have
contributed to these figures as has been reported by others
[29]. However, it should be possible to set an optimal target
of <3% in elective cases [2]. The average age of our study
population was 71 years and that may be older than in
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series of selected patients. The average age of men and
women in our country for those that have reached the age
of 62 (earliest OAP retirement age) is 81 and 85 years. To
circumvent the analytic problem of age, Sjo et al. [28] used
relative survival. Thus, their survival figures improved from
62% actuarial survival to 74% for women and 79% for
men. The method is cumbersome, as it necessitates life
tables to calculate this for every patient year. Three-year
disease-free survival has been shown to parallel overall 5-
year survival [30]. However, it requires close follow-up
with CT instead of the conventional ultrasonography and
chest X-ray examinations. Close follow-up may even result
in better treatment of metastases according to Japanese
results [31].
Conclusion
Only 41% had a lymph node harvest of 12 or more lymph
nodes, and although this influenced OS in one hospital, it
did not overall. The lymph node ratio was significant for
stage III patients. More radical surgery may increase the
lymph node yield, but if this has the potential to increase
overall survival in our patients remains to be seen in the
prospective registry. Mortality should be kept low with
adequate assessment and treatment of co-morbidities as
well as meticulous surgery to avoid complications.
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